IPO Update: Bicycle Therapeutics Aims For $65 Million U.S. IPO

Bicycle Therapeutics (BCYC) intends to raise $65 million from an IPO of ADSs, according to an amended registration statement.

The company is developing a pipeline of treatment candidates for cancers from its proprietary ‘bicycle’ technology.

Original source

Add comment

Please Sign in to be able to leave comments.